My Authors
Read all threads
Thanks to all my colleagues for voting. This is an interesting question in breast oncology, and practice varies quite a bit (As you can see from the poll)
#medtwitter #breastcancer #OncoAlert #chemo #courtingcontroversy
#oncology
#tweetorial

Thread
1/6
There is interest in getting rid of anthracyclines from adjuvant chemotherapy of breast cancer, due to long-term concerns of heart failure and secondary leukemia. The ABC meta-analysis seemed to concur that taxane+anthracycline (TaxAC) beats 6TC by a small margin
2/6
An unplanned subgroup analysis revealed interaction with number of nodes in HR+ patients, with no benefit in HR+ N0 disease.
3/6
The West German PlanB study compared 6TC to TaxAC in high-risk patients (although lower risk overall than ABC). Of interest, the subgroup analysis reveals no difference in outcomes based on OncotypeDx Recurrence score.
4/6
Two important caveats:
1. PlanB used non-dose dense chemotherapy and TaxAC chemotherapy regimens varied in ABC.
2. Both studies used 6TC as the comparator arm, although 4TC is popular (see poll)

5/6
The final question is still open. Which HR+ N0 patients do you treat with TC instead of TaxAC? None? Only those with contraindications to anthracyclines? Or all?
Importantly, if you are planning TC, patients should not be "upgraded" to TaxAC just because of high RS.

6/6
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Dr Vineet Govinda Gupta

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!